ResearcherInstitute of Science TokyoActive in the last 2 years
Daisuke Asano
Matched on ORCID iD 0000-0002-0867-7572; OpenAlex author ID A5027502577. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 4
- Late-Onset Para-Aortic Lymph Node Recurrence 11 Years after Resection of Pancreatic Cancer: Histological Reassessment Revealed Neuroendocrine Differentiation A… First author DOI 10.70352/scrj.cr.25-0374↗
- Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. Co-author DOI 10.1111/cas.15615↗
- RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer. Co-author DOI 10.3892/ijo.2023.5499↗
- ASO Author Reflections: Clinical Significance of Further Subdivision of N Staging in Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07918-3↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroaki Ono · 2 shared papers, 2023 · strength 0.31
- Paper Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. DOI 10.1111/cas.15615↗
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Shuichi Watanabe · 2 shared papers, 2023 · strength 0.31
- Paper Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. DOI 10.1111/cas.15615↗
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Kosuke Ogawa · 2 shared papers, 2023 · strength 0.31
- Paper Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. DOI 10.1111/cas.15615↗
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Minoru Tanabe · 2 shared papers, 2023 · strength 0.31
- Paper Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. DOI 10.1111/cas.15615↗
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Shinji Tanaka · 2 shared papers, 2023 · strength 0.31
- Paper Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. DOI 10.1111/cas.15615↗
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Eriko Katsuta · 1 shared paper, 2025 · strength 0.24
- Daisuke Ban · 1 shared paper, 2025 · strength 0.24
- Yohei Tabe · 1 shared paper, 2025 · strength 0.24
- Kazuaki Shimada · 1 shared paper, 2019 · strength 0.16
- Satoshi Nara · 1 shared paper, 2019 · strength 0.16
- Yoshiki Murase · 1 shared paper, 2023 · strength 0.16
- Ayano Kabashima · 1 shared paper, 2023 · strength 0.16
- Tomotaka Kato · 1 shared paper, 2023 · strength 0.16
- Takeshi Ishii · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.